Why we exist
Most organizations treat whatever problem is most visible. We mapped the entire ecosystem first — sponsors, sites, labs, and patients — and traced every pain point to its source.
"Patients are giving us precious material: their time, discomfort from their bodies, and hope for their future. Every sample represents trust that must be honored."
Karina Bienfait
Executive Director, Consent, Biospecimen & Imaging Management
BMS
From the BMC Surveys
The reality across sponsors and sites.
74%
of sponsors track samples manually
79%
of sponsors use non-governed data to reconcile samples
33%
of sponsors track missed collections
80%
of sites create their own tools to fill sponsor gaps
70%
of sites flag protocol and lab manual discrepancies as a top issue
$50K–$200K
reported by sponsors lost per study in kit waste alone
Source: BMC Benchmarking Survey Report, 2024; BMC Site Oncology Whitepaper 2026
Why the BMC
Silos created this problem.
We're the only organization built to break them down.
No silos. No observers.
Sponsors, sites, labs, vendors, and patient advocates aren't separate audiences here. They are equal participants, because the people this problem affects most are the ones best positioned to solve it.
Raising the baseline
Through webinars, conference panels, publications, and patient education, we are building shared understanding across the field. Because the gap between what people know and what they practice is part of the problem too.
Led by the people closest to the problem
Every BMC initiative is driven by member-led subcommittees — sponsors, sites, labs, and vendors who live these challenges daily. They set the agenda. They own the outcomes.
Building the common language
The field has no shared baseline. No standard terminology, no aligned planning documents, no common framework. We are building one, and making it freely available to the entire industry.
Latest News
Biospecimen Management Consortium Accelerates Growth, Releases Landmark Industry Survey, and Launches Key Initiatives
Press
PR Newswire
Biospecimen Management Consortium Transitions to a Non-Profit Organization, Names Board of Directors and Steering Committee
Press
PR Newsire
Slope Spearheads Launch of Biospecimen Management Consortium to Drive Sample Excellence in Clinical Research
Press
PR Newswire
